Skip to main content
Caplight Logo









CoreMedic

CoreMedic

Private
RadolfzellHealthcare & Life Scienceshttps://www.coremedic.de/

Last Round

Series B

Extension

Feb 11, 2025

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CoreMedic GmbH is a medical device company that develops a transcatheter mitral valve repair system called ChordArt.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

mitral valve repairtranscatheter mitral valve repairTMVrchordal repairstructural heartmedtechmitral valve regurgitationminimally invasive surgerycardiovascular devicetranscatheter chordal repaircatheter-based repairstructural heart diseaseopen-heart surgery alternativeinterventional cardiologymedical deviceclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CoreMedic Comparables

Compare CoreMedic with similar companies based on industry and business-model similarity.

CoreMedic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardioMech
93%
Polares Medical
89%
NeoChord
85%

CoreMedic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionFeb 11, 2025
VC RoundAug 1, 2017

Key People

Founding team and executive leadership

Thomas Bauer

CEO CTO Managing Director Co-Founder

Founding Team

Rainer Hoegg

Senior Advisor CFO

Executive Team

CoreMedic Investors

Notable investors and investment history

CoreMedic investors
InvestorRounds
SHS Gesellschaft für Beteiligungsmanagement mbHSeries B Extension, VC Round
MIG CapitalSeries B Extension
MIG AGSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 290% MoM.

  • Jan 19, 2026

    Monthly visitors grew 754% MoM, from 142 to 1.2K.

CoreMedic Filings

Explore SEC and related filing metadata, where available.

CoreMedic filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CoreMedic's valuation, stock price, and market status.

Is CoreMedic a public or private company?

CoreMedic is a private company.

What is the current stock price of CoreMedic?

CoreMedic is a private company with no public stock price. No recent secondary market data is available.

How much is CoreMedic worth (valuation)?

Valuation information for CoreMedic is not publicly available.

Can I buy CoreMedic stock?

CoreMedic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CoreMedic's last funding round?

CoreMedic's most recent funding round was Series B Extension on February 11, 2025.

Who are the main investors in CoreMedic?

Key investors in CoreMedic include SHS Gesellschaft für Beteiligungsmanagement mbH, MIG AG.

Will CoreMedic IPO soon?

No public IPO plans have been announced for CoreMedic.

How can I track CoreMedic secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CoreMedic's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRadolfzell
Employee Range13
Year Founded2012
Last FundingFeb 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?